NMPA Releases Compliance Guide for Online Retail of Prescription Drugs

The National Medical Products Administration (NMPA) recently issued the Compliance Guide for Online Retail of Prescription Drugs (Draft for Comment) (the "Draft") for public consultation by September 15, 2025.

The Draft requires enterprises to fulfill their primary responsibilities for drug safety pursuant to the law and continuously improve their drug quality and safety management systems as well as their internal compliance management rules. They shall adopt effective quality control measures in the processes of procurement, storage, sale, and transportation of drugs, ensuring that all drugs sold are sourced lawfully and that the circulation process is traceable. The Draft further specifies that enterprises engaged in online retail of prescription drugs shall obtain approval from drug regulatory authorities, lawfully acquire pharmaceutical trading license, and strictly comply with relevant laws, regulations, rules, standards, and norms. Enterprises shall also continuously disclose relevant qualification information in a prominent position on the homepage of their website or the main page of their business operation in the form of text or image, and ensure that such information is authentic, clear, and legible.



(Source: https://www.nmpa.gov.cn/xxgk/zhqyj/zhqyjyp/20250908164504121.html)

Note: The link to the Chinese official website of the document is for your reference.